The US Food and Drug Administration (FDA) has announced the launch of a new pilot programme. This programme aims to accelerate the review process for generic drugs. Companies research, develop, and manufacture these drugs entirely within the United States. The initiative aims to incentivise pharmaceutical companies to onshore their operations. It strengthens the domestic supply…
FDA Generic Drug Review Boosts US Drug Manufacturing
Original Article by Siddhi Mahatole | Reuters | 5 October 2025
The US Food and Drug Administration (FDA) has announced the launch of a new pilot programme. This programme aims to accelerate the review process for generic drugs. Companies research, develop, and manufacture these drugs entirely within the United States. The initiative aims to incentivise pharmaceutical companies to onshore their operations. It strengthens the domestic supply […]
More Posts
Older Adults With HIV Set To Double By 2040
Older adults with HIV will nearly double by 2040. South Africa faces one of the sharpest rises, straining health systems.
Read more...
Rosebank Health Village Expands Growthpoint Portfolio
Rosebank Health Village, a R100 million Growthpoint and Epione development, brings specialists, diagnostics and day surgery together.
Read more...
Global HIV Funding Cuts Put AIDS Progress At Risk
Global HIV funding cuts pushed financing to a 20-year low in 2025, threatening prevention, research and the goal of ending AIDS by 2030.
Read more...